- Release Date: 04/09/12 14:02
- Summary: RELINT: RYM: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 20.84KB
RYM 04/09/2012 12:02 RELINT REL: 1202 HRS Ryman Healthcare Limited RELINT: RYM: Disclosure of Directors and Officers Relevant Interests Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: David William Kerr Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Director B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 812,878 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Registered Holder, as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) N/a Consideration paid for acquisition: 5) N/a If the relevant interest was disposed of-- Date of disposal: 6) 28 August 2012 Consideration received for disposal: 7) Transfer of 812,878 shares to Ryman Employees in accordance with three year vesting terms of the Ryman Healthcare Limited Employee Share Purchase Scheme. Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) Transfer of shares to Ryman Employees in accordance with three year vesting terms of the Ryman Healthcare Limited Employee Share Purchase Scheme. E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 30 January 2012 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Andrew John Clements Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Director B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 812,878 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Registered Holder, as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) N/a Consideration paid for acquisition: 5) N/a If the relevant interest was disposed of-- Date of disposal: 6) 28 August 2012 Consideration received for disposal: 7) Transfer of 812,878 shares to Ryman Employees in accordance with three year vesting terms of the Ryman Healthcare Limited Employee Share Purchase Scheme. Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) Transfer of shares to Ryman Employees in accordance with three year vesting terms of the Ryman Healthcare Limited Employee Share Purchase Scheme. E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 30 January 2012 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: David William Kerr Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Director B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 766,271 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Registered Holder, as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $2,925,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) N/a Consideration received for disposal: 7) N/a Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market purchase E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 30 January 2012 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Andrew John Clements Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Director B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 766,271 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Registered Holder, as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $2,925,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) N/a Consideration received for disposal: 7) N/a Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market purchase E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 30 January 2012 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Simon Challies Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Managing Director B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 235,776 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $900,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) N/a Consideration received for disposal: 7) N/a Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market purchase E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 18 August 2011 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Gordon MacLeod Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 104,789 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $400,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) N/a Consideration received for disposal: 7) N/a Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market purchase E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 4 January 2012 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Barbara Reynen Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Operations Manager B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 65,493 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $250,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) N/a Consideration received for disposal: 7) N/a Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market purchase E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 18 August 2011 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Jenn Poskitt Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Marketing Manager B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) 19,649 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $75,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) N/a Consideration received for disposal: 7) N/a Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market purchase E Total number of transactions this notice relates to: 9) One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) N/a G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Debbie Versey Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Sales Manager B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) (19,734) Ordinary shares (net) C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme and Debbie Versey D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $250,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) 31 August 2012 Consideration received for disposal: 7) $324,715 (or $3.82 per share) Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market sale and purchase E Total number of transactions this notice relates to: 9) Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 13 December 2011 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Andrew Mitchell Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Development Manager B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) (45,232) Ordinary shares (net) C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme and Andrew Mitchell D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $250,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) 31 August 2012 Consideration received for disposal: 7) $421,862 (or $3.82 per share) Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market sale and purchase E Total number of transactions this notice relates to: 9) Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 18 August 2011 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Ongoing Disclosure Notice Disclosure of Directors and Officers Relevant Interests Section 19T(2), Securities Markets Act 1988 A Details of director or officer Name of director or officer of public issuer: Tom Brownrigg Name of public issuer: Ryman Healthcare Ltd Name of related body corporate (if applicable): Position held in public issuer: Construction Manager B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 1) (39,835) Ordinary shares (net) C Nature of relevant interest and name of registered holder Nature of relevant interest in those securities: 2) Beneficial Owner subject to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme Name of registered holder of those securities 3) David William Kerr and Andrew John Clements as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme and Tom Brownrigg D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4) 31 August 2012 Consideration paid for acquisition: 5) $250,000 (or $3.82 per share) If the relevant interest was disposed of-- Date of disposal: 6) 31 August 2012 Consideration received for disposal: 7) $401,300 (or $3.82 per share) Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: 8) On market sale and purchase E Total number of transactions this notice relates to: 9) Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10) 18 August 2011 G Signature Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Gordon MacLeod Date of signature: 4 September 2012 Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary Notes: Use this form to disclose all the acquisitions and disposals by a director or officer of a public issuer of relevant interests in securities of the public issuer or of a related body corporate. The disclosure must normally be made within 5 trading days of the first acquisition or disposal disclosed in this notice "Provide the information required under headings C and D for each type of security identified under heading B. " "This notice must be signed either by the director or officer making the disclosure, or by a person authorised by the director or officer to sign on his or her behalf.11 " References 1. Regulation 8. 2. Regulation 7. 3. Regulation 7. 4. Regulation 9. 5. Regulation 10. 6. Regulation 9. 7. Regulation 10. 8. Regulation 11. 9. Regulation 12 (2) 10. Regulation 13. 11. Regulation 14. End CA:00226883 For:RYM Type:RELINT Time:2012-09-04 12:02:10
Add to My Watchlist
What is My Watchlist?
